SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001078782-17-001266
Filing Date
2017-09-14
Accepted
2017-09-14 11:23:49
Documents
77
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10QA AMENDED QUARTERLY REPORT f10qa063017_10qz.htm 10-Q/A 435684
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10qa063017_ex31z1.htm EX-31.1 7173
3 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10qa063017_ex31z2.htm EX-31.2 7327
4 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10qa063017_ex32z1.htm EX-32.1 3436
5 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10qa063017_ex32z2.htm EX-32.2 3414
  Complete submission text file 0001078782-17-001266.txt   2401963

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axim-20170630_cal.xml EX-101.CAL 21150
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20170630_def.xml EX-101.DEF 100434
8 XBRL INSTANCE DOCUMENT axim-20170630.xml EX-101.INS 312498
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20170630_lab.xml EX-101.LAB 173287
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20170630_pre.xml EX-101.PRE 172119
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20170630.xsd EX-101.SCH 44015
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54296 | Film No.: 171085004
SIC: 2834 Pharmaceutical Preparations